Latest Salman Hyder Stories
Apigenin Slowed The Progression of a Human Cancer Accelerated by Hormone Replacement Therapy
Parsley is usually used as a decorative accent to a scrumptious meal, but donâ€™t set it aside just yet.
A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells.
After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries.
Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors.
Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic treatment for progestin-accelerated human breast cancer.
- A political dynamiter.